Premium
Early clinical experience with the 6 French Angio‐Seal™ device: Immediate closure of femoral puncture sites after diagnostic and interventional coronary procedures
Author(s) -
Eggebrecht Holger,
Haude Michael,
von Birgelen Clemens,
Woertgen Uta,
Schmermund Axel,
Baumgart Dietrich,
Kaiser Christoph,
Naber Christoph K.,
Kroeger Knut,
Erbel Raimund
Publication year - 2001
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.1198
Subject(s) - medicine , hemostasis , vascular closure device , cardiac catheterization , angioplasty , surgery , femoral artery , femoral vein , prospective cohort study , radiology
The objective of this study was to assess the early safety and efficacy of the novel 6 Fr Angio‐Seal device for routine clinical use after diagnostic cardiac catheterization and coronary angioplasty. In a prospective study, we used the 6 Fr Angio‐Seal™ device in 180 consecutive patients (131 male, 49 female, mean age 60.7 years) for closure of femoral arterial puncture sites immediately after diagnostic (n = 108) or interventional (n = 72) coronary procedures independent of the coagulation status. All patients were monitored for 24 hr after the procedure and followed for 30 days. The closure device was successfully deployed in 95.4% after diagnostic catheterization versus 98.6% after coronary angioplasty ( P = 0.963). Immediate hemostasis was achieved in 91.5% versus 90.1% of the patients ( P = 0.993). Major complications were observed 1.9% versus 2.8% of the patients ( P = 0.885). During 30‐day follow‐up, no late events or complications were reported. The 6 Fr Angio‐Seal™ device is a safe and effective device that allows for immediate closure of femoral puncture sites after both diagnostic and interventional procedures with a low rate of major complications. Cathet Cardiovasc Intervent 2001;53:437–442. © 2001 Wiley‐Liss, Inc.